These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1344973)

  • 21. [Treatment of stage I-IIA breast cancer of medial-central localization].
    Datsenko VS
    Khirurgiia (Mosk); 1998; (11):35-7. PubMed ID: 9864983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Surgical, radiation and drug treatment of breast cancer].
    Pereslegin IA; Nikitina TP
    Med Radiol (Mosk); 1990 Jun; 35(6):39-44. PubMed ID: 2192219
    [No Abstract]   [Full Text] [Related]  

  • 23. High-dose therapy for the treatment of breast cancer: evaluation of effect of regimen on outcome.
    Fields KK; Perkins JB; Partyka JS; Elfenbein GJ
    Bone Marrow Transplant; 1996 Sep; 18 Suppl 1():S30-3. PubMed ID: 8899167
    [No Abstract]   [Full Text] [Related]  

  • 24. [Adjuvant chemotherapy in primary breast cancer].
    Harbeck N
    Onkologie; 2003 Dec; 26 Suppl 7():17-20. PubMed ID: 14716137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discouraging news for high-dose chemotherapy in high-risk breast cancer.
    Pusztai L; Hortobagyi GN
    Lancet; 1998 Aug; 352(9127):501-2. PubMed ID: 9716049
    [No Abstract]   [Full Text] [Related]  

  • 26. Systemic therapy of breast cancer in early and advanced disease.
    Layhe B; Dimitrov N
    J Am Med Womens Assoc (1972); 1992; 47(5):188-93. PubMed ID: 1460224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjuvant and neoadjuvant treatment of breast cancer with chemotherapy and/or endocrine therapy.
    Bonadonna G; Valagussa P; Brambilla C; Moliterni A; Zambetti M; Ferrari L
    Semin Oncol; 1991 Dec; 18(6):515-24. PubMed ID: 1775970
    [No Abstract]   [Full Text] [Related]  

  • 28. Intensification of adjuvant chemotherapy in patients with primary breast cancer and positive axillary nodes.
    Elias EG
    Md Med J; 1990 Dec; 39(12):1072-3. PubMed ID: 2266815
    [No Abstract]   [Full Text] [Related]  

  • 29. Dose-dense chemotherapy for breast cancer: what does the future hold?
    Morris PG; McArthur HL; Hudis C; Norton L
    Future Oncol; 2010 Jun; 6(6):951-65. PubMed ID: 20528233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast cancer 1984: state of the art.
    Sledge GW
    Indiana Med; 1984 Dec; 77(12):935-9. PubMed ID: 6394645
    [No Abstract]   [Full Text] [Related]  

  • 31. Adjuvant chemotherapy for lymph node-negative, estrogen receptor-negative breast cancer: a tale of three trials.
    Albain KS
    J Natl Cancer Inst; 2004 Dec; 96(24):1801-4. PubMed ID: 15601631
    [No Abstract]   [Full Text] [Related]  

  • 32. Adjuvant chemotherapy in breast cancer: back to the future.
    Colleoni M; Goldhirsch A
    Onkologie; 2003 Apr; 26(2):111-2. PubMed ID: 12771517
    [No Abstract]   [Full Text] [Related]  

  • 33. [Breast cancer: the majority of women need adjuvant therapy. Even in the absence of lymphatic metastases adjuvant therapy can be useful].
    Schalhorn B
    Fortschr Med; 1999 Apr; 117(12):35. PubMed ID: 10361370
    [No Abstract]   [Full Text] [Related]  

  • 34. [Sequencing of adjuvant treatment after surgery for invasive breast cancer].
    Petit T; Claude L; Carrie C
    Cancer Radiother; 2004 Feb; 8(1):54-8. PubMed ID: 15093202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sequential adjuvant therapy with doxorubicin/paclitaxel/cyclophosphamide for resectable breast cancer involving four or more axillary nodes.
    Hudis CA; Seidman AD; Baselga J; Raptis G; Lebwohl D; Gilewski T; Currie V; Moynahan ME; Sklarin N; Fennelly D
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):18-23. PubMed ID: 8643965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [-Adjuvant systemic therapy of breast carcinoma-].
    Goldhirsch A; Castiglione-Gertsch M
    Arch Gynecol Obstet; 1995; 256 Suppl():S93-103. PubMed ID: 8619668
    [No Abstract]   [Full Text] [Related]  

  • 37. A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors.
    Fisher B; Redmond C; Dimitrov NV; Bowman D; Legault-Poisson S; Wickerham DL; Wolmark N; Fisher ER; Margolese R; Sutherland C
    N Engl J Med; 1989 Feb; 320(8):473-8. PubMed ID: 2644531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomised trial of high-dose chemotherapy and haemopoietic progenitor-cell support in operable breast cancer with extensive axillary lymph-node involvement.
    Rodenhuis S; Richel DJ; van der Wall E; Schornagel JH; Baars JW; Koning CC; Peterse JL; Borger JH; Nooijen WJ; Bakx R; Dalesio O; Rutgers E
    Lancet; 1998 Aug; 352(9127):515-21. PubMed ID: 9716055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A case of breast cancer with multiple organ metastases responding remarkably to combination therapy of CAF (cyclophosphamide, adriamycin and 5-FU), 5'-DFUR and MPA (medroxyprogesterone acetate)].
    Maruyama S; Okumoto T; Kawasaki K; Ino H; Kanaya Y; Otani J; Yokoyama N; Soda M
    Gan To Kagaku Ryoho; 2000 Dec; 27(14):2235-8. PubMed ID: 11142168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Late effects of adjuvant therapy for breast cancer.
    Shapiro CL; Recht A
    J Natl Cancer Inst Monogr; 1994; (16):101-12. PubMed ID: 7999452
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.